Who has invested in Sidera Bio?

Novo Holdings, Forbion, RA Capital Healthcare Fund, Gilde Healthcare are named among the investors backing Sidera Bio.

Sidera Bio Funding: $109M Raised, Series A (2025)

Sidera Bio funding overview

Sidera Bio is based in Copenhagen, Denmark. Sidera Bio has raised $109M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in December 2025. The round record for Sidera Bio runs through 2025; nothing later has been disclosed. Investors on record include Novo Holdings, Forbion, RA Capital Healthcare Fund, Gilde Healthcare. 4 distinct backers are named across the disclosed rounds.

Sidera Bio at a glance

Total raised: $109M
Latest round: Series A
Latest round date: December 2025
Headquarters: Copenhagen, Denmark
Notable investors: Novo Holdings, Forbion, RA Capital Healthcare Fund, Gilde Healthcare

Frequently asked about Sidera Bio funding

How much has Sidera Bio raised?: Sidera Bio has raised $109M in total disclosed funding across the rounds on record.
Who has invested in Sidera Bio?: Novo Holdings, Forbion, RA Capital Healthcare Fund, Gilde Healthcare are named among the investors backing Sidera Bio.
What was the latest Sidera Bio funding round?: The most recent disclosed round is a Series A, announced in December 2025.
Where is Sidera Bio based?: Sidera Bio is based in Copenhagen, Denmark.
When did Sidera Bio last raise?: The last disclosed Sidera Bio round closed in December 2025 at Series A.

Totals shown for Sidera Bio aggregate every disclosed round on file. To see how that compares, browse the companies in Copenhagen and the investors behind them below.

Sidera Bio Funding: $109M Raised, Series A (2025)

Sidera Bio funding overview

Sidera Bio at a glance

Frequently asked about Sidera Bio funding

Companies related to Sidera Bio (36)

Browse related funding lists (6)